Request Trial
canada-istock-471706898-mironovak--2
mironovak / iStockphoto.com
2 October 2017Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell

Why you shouldn’t overlook Canadian IP litigation

While Canada is known for its natural resources and universal healthcare, it is often overlooked as a jurisdiction to litigate IP disputes.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026   Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product.
Americas
Novartis takes aim at Tafinlar generic in latest suit
9 February 2026   The Swiss pharma giant moves to protect patents on its billion-dollar cancer therapy following an ANDA filing by a Canadian generics manufacturer.
Americas
Semaglutide patent battle heats up with new blow for Novo in India
6 February 2026   A Delhi High Court ruling signals more bad news for the Danish pharma giant in the same week that it lost nearly $50 billion in value.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

Rooted in rights: Lessons from plant patent infringement and invalidity cases
How AI will be shaped by legal and regulatory developments in 2026
Key EU and UK regulatory changes to watch for in 2026
Regeneron v Alvotech: The big impact
Beyond traditional IP: A comprehensive AI strategy for life sciences
Prosecuting bispecific antibody patents: A cookbook for patent chefs
EU Pharma Package hits the final stretch—but can negotiators agree?
The clinical trial dilemma: Navigating European practice